Funder
National Institutes of Health
Wellcome Trust
Howard Hughes Medical Institute
Reference46 articles.
1. Germline genetic testing in breast cancer: systemic therapy implications;Bhardwaj;Curr Oncol Rep,2022
2. Associations between cancer predisposition testing panel genes and breast cancer;Couch;JAMA Oncol,2017
3. Germline genetic testing: what the breast surgeon needs to know;Plichta;Ann Surg Oncol,2019
4. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2;Schoolmeester;Hum Pathol,2017
5. Synchronous breast cancers with different morphologic and molecular phenotypes occurring in Lynch syndrome: what does the heterogeneity imply?;D'Arcy;Am J Surg Pathol,2011